9 Million
Global
Potential Patients
6.3 Million
Potential Patients in Africa
$4.0
Billion / Year
Total Available Market (TAM)
in Africa
IMCI has the opportunity to be the first one to develop and introduce new pharmaceutical, patented, and effective cannabinoid-based treatments to treat
a specific neuropathic health condition.